AUR Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline MDXG Q1 2026 Earnings EPS Misses Estimates as GAAP Loss Widens Upstream Bio UPB Q1 2026 Earnings NarrowerthanExpected Loss with No Revenue Yet FHN Q1 2026 Earnings EPS Beats Estimates by Over 6 Shares Edge Higher Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn HGTY Q1 2026 Earnings NarrowerThanExpected Loss Drives Small Beat Shares Slip